Shanghai, China

Zhong Shi Wang

USPTO Granted Patents = 14 

 


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Guangzhou, CN (2022)
  • Beijing, CN (2023)
  • Shanghai, CN (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):

Title: Innovations in Tumor Immunotherapy by Inventor Zhong Wang

Introduction

Zhong Wang, an innovative inventor based in Guangzhou, China, has made noteworthy contributions to the field of biotechnology. His groundbreaking work focuses on enhancing tumor-targeting therapies, aiming to improve cancer treatment through advanced medical innovations. With a singular patent to his name, Wang's research has the potential to significantly impact the fight against cancer.

Latest Patents

Zhong Wang holds a patent for an "Interleukin 15 fusion protein for tumor targeting therapy." This invention involves a specialized tumor-targeting fusion protein that comprises an IL-15 peptide, an IL-15Rα polypeptide, an Fc domain, and an RGD polypeptide. The innovative configuration of the protein, designed as RGD polypeptide-Fc domain-IL-15 polypeptide-IL-15Rα polypeptide, enhances the anti-tumor effects of IL-15 while prolonging its half-life. The fusion proteins also demonstrate efficient expression and purification capabilities, presenting themselves as excellent candidates for tumor immunotherapy.

Career Highlights

Throughout his career, Zhong Wang has been associated with reputable institutions, including Bj Bioscience Inc. and Tsinghua University. His affiliation with these organizations showcases his commitment to research and development in the field of biotechnology. Wang’s innovative work has earned him recognition in the scientific community, particularly in the area of cancer immunotherapy.

Collaborations

Wang has collaborated with notable professionals, including his coworker Qing Li. These partnerships have played a crucial role in advancing his research and facilitating the development of cutting-edge therapeutic solutions.

Conclusion

Zhong Wang's contributions to tumor-targeting therapies through his patent of the Interleukin 15 fusion protein mark a significant milestone in cancer research. His innovative approach not only addresses the challenges posed by tumors but also opens up new avenues for immunotherapy, potentially transforming treatments for cancer patients worldwide. As research continues, Wang's work will likely inspire further advancements in the field and contribute to improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…